Our results showed that glucose dose-dependently increased mRNA expressions of ADM and its receptor components CRLR, RAMP2 and RAMP3 (Fig 3A) suggesting the association between hyperglycemia and elevated ADM in diabetic patients. The gene discussed is CALCRL; the disease is Hyperglycemia.